Both in Pharmaceuticals
Phathom Pharmaceuticals vs CorMedix
Over the past year PHAT returned −57.9% and CRMD returned −50.4%; their daily moves had a correlation of 0.26.
PHAT −57.9% CRMD −50.4%Growth of $1, one year, split-adjusted
| Metric | PHAT | CRMD |
|---|---|---|
| Price | $5.68 | $5.66 |
| Market cap | $461.7M | $441.2M |
| Today | −1.05% | +1.80% |
| 1 month | −16.2% | −22.3% |
| 6 months | −55.2% | −29.7% |
| Year to date | −65.8% | −51.3% |
| 1 year | −58.6% | −51.0% |
| Revenue growth (YoY) | +71.1% | +156.5% |
| Gross margin | 78.3% | 75.7% |
| Net margin | −16.4% | 25.5% |
| P/E (TTM) | — | 2.4× |
| Price / sales | 1.7× | 1.0× |
| Net cash | $17.6M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 77.3% |
| Short % of float | 17.5% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).